Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
5 "Won Hwangbo"
Filter
Filter
Article category
Keywords
Publication year
Authors
Brief Case Report
Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Uterine Corpus
Eung-Seok Lee, Won Hwangbo, Insun Kim
J Pathol Transl Med. 2015;49(1):66-70.   Published online January 15, 2015
DOI: https://doi.org/10.4132/jptm.2014.10.14
  • 10,515 View
  • 87 Download
  • 3 Web of Science
  • 4 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Primary uterine Ewing sarcoma – A case report
    Yen-Chen Wu, Yu-Chien Kao, Ching-Wen Chang
    Taiwanese Journal of Obstetrics and Gynecology.2021; 60(1): 142.     CrossRef
  • Adjuvant chemotherapy for a primitive neuroectodermal tumor of the uterine corpus: A case report and literature review
    Munetoshi Akazawa, Toshiaki Saito, Kazuya Ariyoshi, Masao Okadome, Ryohei Yokoyama, Kenichi Taguchi
    Journal of Obstetrics and Gynaecology Research.2018; 44(10): 2008.     CrossRef
  • Clinicopathologic Features of the Non-CNS Primary Ewing Sarcoma Family of Tumors in the Head and Neck Region
    Chang Gok Woo, Bora Lee, Joon Seon Song, Kyung-Ja Cho
    Applied Immunohistochemistry & Molecular Morphology.2018; 26(9): 632.     CrossRef
  • Primitive neuroectodermal tumor of uterus with synchronous in situ squamous cell carcinoma of cervix–A rare tumor with unusual association
    Ramneet Kaur, Shashi Dhawan, Prem Chopra, Sunita Bhalla
    Current Medicine Research and Practice.2017; 7(3): 109.     CrossRef
Letter to the Editor
Myxoid Solitary Fibrous Tumor of the Central Nervous System
Haeri Han, Sangjeong Ahn, Won Hwangbo, Yang Seok Chae
Korean J Pathol. 2013;47(6):505-506.   Published online December 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.6.505
  • 5,573 View
  • 37 Download
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Cervical Myxoid Solitary Fibrous Tumor: Report of an Unusual Variant and a Brief Overview of the Literature
    Bingcheng Wu, Sok Yan Tay, Fredrik Petersson
    Head and Neck Pathology.2020; 14(3): 852.     CrossRef
Case Study
Myxoid Liposarcoma with Cartilaginous Differentiation: A Case Study with Cytogenetical Analysis
Hyunchul Kim, Won Hwangbo, Sangjeong Ahn, Suhjin Kim, Insun Kim, Chul Hwan Kim
Korean J Pathol. 2013;47(3):284-288.   Published online June 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.3.284
  • 7,071 View
  • 40 Download
  • 3 Crossref
AbstractAbstract PDF

Myxoid liposarcoma is a subtype of liposarcoma. This specific subtype can be identified based on its characteristic histological and cytogenetical features. The tumor has a fusion transcript of the CHOP and TLS genes, which is caused by t(12;16)(q13;p11). Most of the fusion transcripts that have been identified fall into three categories, specifically type I (exons 7-2), type II (exons 5-2), and type III (exons 8-2). A total of seven myxoid liposarcomas associated with the rare phenomenon of cartilaginous differentiation have been documented in the literature. Currently, only one of these cases has been cytogenetically analyzed, and the analysis indicated that it was a type II TLS-CHOP fusion transcript in both the typical myxoid liposarcoma and cartilaginous areas. This study presents a second report of myxoid liposarcoma with cartilaginous differentiation, and includes a cytogenetical analysis of both the myxoid and cartilaginous areas.

Citations

Citations to this article as recorded by  
  • Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study
    Naoki Kojima, Takashi Kubo, Taisuke Mori, Kaishi Satomi, Yuko Matsushita, Shintaro Iwata, Yasushi Yatabe, Koichi Ichimura, Akira Kawai, Hitoshi Ichikawa, Akihiko Yoshida
    Virchows Archiv.2024; 484(1): 71.     CrossRef
  • The Conundrum of Dedifferentiation in a Liposarcoma at a Peculiar Location: A Case Report and Literature Review
    Ana-Maria Ciongariu, Adrian-Vasile Dumitru, Cătălin Cîrstoiu, Bogdan Crețu, Maria Sajin, Dana-Antonia Țăpoi, Aminia-Diana Ciobănoiu, Adrian Bejenariu, Andrei Marin, Mariana Costache
    Medicina.2023; 59(5): 967.     CrossRef
  • Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement
    Kayo Suzuki, Taketoshi Yasuda, Kenta Watanabe, Takeshi Hori, Masahiko Kanamori, Tomoatsu Kimura
    Oncology Letters.2017;[Epub]     CrossRef
Original Articles
Naked Cuticle Drosophila 1 Expression in Histologic Subtypes of Small Adenocarcinoma of the Lung
Sangjeong Ahn, Won Hwangbo, Hyunchul Kim, Chul Hwan Kim
Korean J Pathol. 2013;47(3):211-218.   Published online June 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.3.211
  • 6,066 View
  • 27 Download
  • 12 Crossref
AbstractAbstract PDF
Background

Naked cuticle Drosophila 1 (NKD1) has been related to non-small cell lung cancer in that decreased NKD1 levels have been associated with both poor prognosis and increased invasive quality.

Methods

Forty cases of lung adenocarcinoma staged as Tis or T1a were selected. Cases were subclassified into adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA), and small adenocarcinoma (SAD). Immunohistochemical studies for NKD1 were performed.

Results

Forty samples comprised five cases of AIS (12.5%), eight of MIA (20.0%), and 27 of SAD (67.5%). AIS and MIA showed no lymph node metastasis and 100% disease-free survival, whereas among 27 patients with SAD, 2 (7.4%) had lymph node metastasis, and 3 (11.1%) died from the disease. Among the 40 cases, NKD1-reduced expression was detected in 8 (20%) samples, whereas normal expression was found in 15 (37.5%) and overexpression in 17 (42.5%). Loss of NKD1 expression was significantly associated with lymph node metastasis (p=0.001). All cases with predominant papillary pattern showed overexpression of NKD1 (p=0.026).

Conclusions

Among MIA and SAD, MIA had better outcomes than SAD. Down-regulated NKD1 expression was closely associated with nodal metastasis, and overexpression was associated with papillary predominant adenocarcinoma.

Citations

Citations to this article as recorded by  
  • Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma
    Yu‐Ting Wang, Il‐Chi Chang, Chih‐Yi Chen, Jiun‐Yi Hsia, Frank Cheau‐Feng Lin, Wan‐Ru Chao, Tuan‐Ying Ke, Ya‐Ting Chen, Chih‐Jung Chen, Min‐Shu Hsieh, Shiu‐Feng Huang
    Thoracic Cancer.2023; 14(6): 592.     CrossRef
  • Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma
    Lijun Li, Ruiying Gao, Weizhong Huangfu, Fang Zhang, Ruixia Wang, Hongda Liu
    Genetics Research.2023; 2023: 1.     CrossRef
  • Naked cuticle homolog 1 prevents mouse pulmonary arterial hypertension via inhibition of Wnt/β-catenin and oxidative stress
    Shanwu Wei, Lu Lin, Wen Jiang, Jie Chen, Gu Gong, Daming Sui
    Aging.2023;[Epub]     CrossRef
  • MicroRNA‐195‐5p suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog 1
    Qiang Qu, Xiangdong Chu, Peng Wang
    Cell Biology International.2017; 41(3): 287.     CrossRef
  • Downregulation of NKD1 in human osteosarcoma and its clinical significance
    Xiang Chen, Ping Xu, Jianwei Zhu, Fan Liu
    Molecular Medicine Reports.2017;[Epub]     CrossRef
  • Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma
    Madhusmita Behera, Taofeek K. Owonikoko, Anthony A. Gal, Conor E. Steuer, Sungjin Kim, Rathi N. Pillai, Fadlo R. Khuri, Suresh S. Ramalingam, Gabriel L. Sica
    Clinical Lung Cancer.2016; 17(5): e57.     CrossRef
  • The NKD1/Rac1 feedback loop regulates the invasion and migration ability of hepatocarcinoma cells
    Jie Li, Sheng Zhang, Qing Hu, Kang Zhang, Jianbin Jin, Xuqing Zheng, Zhenyu Yin, Xiaomin Wang
    Scientific Reports.2016;[Epub]     CrossRef
  • NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma
    Sheng Zhang, Jie Li, Xiaomin Wang
    Tumor Biology.2016; 37(10): 14059.     CrossRef
  • Expression pattern and clinicopathologic significance of NKD1 in human primary hepatocellular carcinoma
    Sheng Zhang, Jie Li, Zhen‐Yu Yin, Ping‐Guo Liu, Wen‐Xiu Zhao, Cheng‐Rong Xie, Bi‐Xin Zhao, Xiao‐Min Wang
    APMIS.2015; 123(4): 315.     CrossRef
  • Early lung cancer with lepidic pattern
    Wilko Weichert, Arne Warth
    Current Opinion in Pulmonary Medicine.2014; 20(4): 309.     CrossRef
  • Altered Expression of PTEN and Its Major Regulator MicroRNA-21 in Pulmonary Neuroendocrine Tumors
    Hyoun Wook Lee, Seung Yeon Ha, Mee Sook Roh
    Korean Journal of Pathology.2014; 48(1): 17.     CrossRef
  • The New 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma in Resected Specimens: Clinicopathologic Relevance and Emerging Issues
    Seung Yeon Ha, Mee Sook Roh
    Korean Journal of Pathology.2013; 47(4): 316.     CrossRef
EGFR Gene Amplification and Protein Expression in Invasive Ductal Carcinoma of the Breast
Won Hwangbo, Jeong Hyeon Lee, Sangjeong Ahn, Seojin Kim, Kyong Hwa Park, Chul Hwan Kim, Insun Kim
Korean J Pathol. 2013;47(2):107-115.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.107
  • 11,183 View
  • 66 Download
  • 14 Crossref
AbstractAbstract PDF
Background

The epidermal growth factor receptor (EGFR) is a surrogate marker for basal-like breast cancer. A recent study suggested that EGFR may be used as a target for breast cancer treatment.

Methods

A total of 706 invasive ductal carcinomas (IDC) of the breast were immunophenotyped, and 82 cases with EGFR protein expression were studied for EGFR gene amplification.

Results

EGFR protein was expressed in 121 of 706 IDCs (17.1%); 5.9% were of luminal type, 25.3% of epidermal growth factor receptor 2 (HER-2) type, and 79.3% of basal-like tumors. EGFR gene amplification and high polysomy (fluorescent in situ hybridization [FISH]-positive) were found in 18 of 82 cases (22.0%); 41.2% of the HER-2+, EGFR+, cytokeratin 5/6- (CK5/6-) group, 11.2% of the HER-2-, EGFR+, CK5/6- group, and 19.1% of the HER-2-, EGFR+, CK5/6+ group. FISH-positive cases were detected in 8.3% of the EGFR protein 1+ expression cases, 15.9% of 2+ expression cases, and 38.5% of 3+ expression cases. In group 2, the tumors had a high Ki-67 labeling (>60%), but the patients showed better disease-free survival than those with tumors that co-expressed HER-2 or CK5/6.

Conclusions

EGFR-directed therapy can be considered in breast cancer patients with EGFR protein overexpression and gene amplification, and its therapeutic implication should be determined in HER-2 type breast cancer patients.

Citations

Citations to this article as recorded by  
  • Identification of a cross-talk between EGFR and Wnt/beta-catenin signaling pathways in HepG2 liver cancer cells
    Gurjinder Singh, Md Mehedi Hossain, Aadil Qadir Bhat, Mir Owais Ayaz, Nasima Bano, Rafiqa Eachkoti, Mohd Jamal Dar
    Cellular Signalling.2021; 79: 109885.     CrossRef
  • Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
    Shailendra K. Gautam, Ranjana K. Kanchan, Jawed A. Siddiqui, Shailendra K. Maurya, Sanchita Rauth, Naveenkumar Perumal, Pranita Atri, Ramakanth C. Venkata, Kavita Mallya, Sameer Mirza, Moorthy P. Ponnusamy, Vimla Band, Sidharth Mahapatra, Maneesh Jain, Su
    Cancers.2020; 12(10): 2838.     CrossRef
  • Evaluation of lapatinib cytotoxicity and genotoxicity on MDA-MB-231 breast cancer cell line
    Mona A.M. Abo-Zeid, Mahmoud T. Abo-Elfadl, Amira M. Gamal-Eldeen
    Environmental Toxicology and Pharmacology.2019; 71: 103207.     CrossRef
  • Improved characterization of the relationship between long intergenic non‐coding RNA Linc00152 and the occurrence and development of malignancies
    Jiasheng Xu, Jingjing Guo, Yangkai Jiang, Yujun Liu, Kaili Liao, Zhonghua Fu, Zhenfang Xiong
    Cancer Medicine.2019; 8(10): 4722.     CrossRef
  • Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome
    Ge Yan, Mohamed E.M. Saeed, Sebastian Foersch, Jose Schneider, Wilfried Roth, Thomas Efferth
    Oncotarget.2019; 10(20): 1918.     CrossRef
  • A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K/AKT signaling pathways
    Xiao Sun, Xiao-bin Zhuo, Yi-ping Hu, Xuan Zheng, Qing-jie Zhao
    Molecular and Cellular Biochemistry.2018; 449(1-2): 47.     CrossRef
  • lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway
    Yan Zhang, Cheng Xiang, Yuling Wang, Yuanyuan Duan, Ci Liu, Yongli Jin, Yajing Zhang
    Biomedicine & Pharmacotherapy.2017; 94: 644.     CrossRef
  • Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients
    Areej Fatima, Fomaz Tariq, Muhammad Faraz Arshad Malik, Muhammad Qasim, Farhan Haq
    Journal of Breast Cancer.2017; 20(3): 246.     CrossRef
  • Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
    Malgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, Brigitte Rack, Wolfgang Janni, Peter A. Fasching, Erich-Franz Solomayer, Bahriye Aktas, Sabine Kasimir-Bauer, Klaus Pantel, Tanja Fehm, Volkmar Müller
    Scientific Reports.2017;[Epub]     CrossRef
  • EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib
    James P. De Andrade, Jung M. Park, Vivian W. Gu, George W. Woodfield, Mikhail V. Kulak, Allison W. Lorenzen, Vincent T. Wu, Sarah E. Van Dorin, Philip M. Spanheimer, Ronald J. Weigel
    Molecular Cancer Therapeutics.2016; 15(3): 503.     CrossRef
  • Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer
    H J Lee, A N Seo, E J Kim, M H Jang, Y J Kim, J H Kim, S-W Kim, H S Ryu, I A Park, S-A Im, G Gong, K H Jung, H J Kim, S Y Park
    British Journal of Cancer.2015; 112(1): 103.     CrossRef
  • Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma
    GANG LIN, XIAO-JIANG SUN, QIAN-BO HAN, ZHUN WANG, YA-PING XU, JIA-LEI GU, WEI WU, GU ZHANG, JIN-LIN HU, WEN-YONG SUN, WEI-MIN MAO
    Oncology Letters.2015; 10(2): 901.     CrossRef
  • Immunohistochemical Classification of Primary and Secondary Glioblastomas
    Kyu Sang Lee, Gheeyoung Choe, Kyung Han Nam, An Na Seo, Sumi Yun, Kyung Ju Kim, Hwa Jin Cho, Sung Hye Park
    Korean Journal of Pathology.2013; 47(6): 541.     CrossRef
  • A Comparison of Tumor Biology in Primary Ductal CarcinomaIn SituRecurring as Invasive Carcinoma versus a NewIn Situ
    Wenjing Zhou, Christine Johansson, Karin Jirström, Anita Ringberg, Carl Blomqvist, Rose-Marie Amini, Marie-Louise Fjallskog, Fredrik Wärnberg
    International Journal of Breast Cancer.2013; 2013: 1.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine